Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
Int J Cardiol. 2018 Dec 15;273:177-182. doi: 10.1016/j.ijcard.2018.09.093. Epub 2018 Sep 27.
Severe mitral regurgitation (MR) on hospital arrival at the onset of acute decompensated heart failure (ADHF) can improve after ADHF treatment because MR is dynamic in nature. This study investigated the clinical significance of the dynamic severe MR on hospital arrival in ADHF patients.
Transthoracic echocardiography was performed on 784 patients hospitalized for ADHF both on arrival and after ADHF treatment, of whom 563 with at least mild MR after ADHF treatment were enrolled and divided into 3 groups based on the MR severity: severe at both times (persistent MR, n = 106); severe on arrival and improved to mild/moderate after ADHF treatment (dynamic MR, n = 149); and mild/moderate at both times (non-significant MR, n = 308). The primary outcome measure was defined as a composite of cardiac death, rehospitalization for heart failure, and mitral valve intervention within 1-year.
The incidence of the primary outcome measure in the dynamic MR group (44.8%) was significantly higher than that in the non-significant MR group (22.1%, adjusted hazard ratio [HR]: 0.50, 95% confidence interval [CI]: 0.34-0.73, P < 0.001), and similar to that in the persistent MR group (44.4%, adjusted HR: 1.08, 95% CI: 0.69-1.67, P = 0.75). The risk of dynamic MR was consistent in the subgroups of patients with reduced (<45%) and preserved left ventricular ejection fraction (P = 0.56).
In patients hospitalized for ADHF, dynamic severe MR on hospital arrival was associated with poorer outcomes than non-significant MR and had similar risk to persistent severe MR. Acute dynamic MR is a potential therapeutic target in ADHF patients.
急性失代偿性心力衰竭(ADHF)发作时,入院时出现严重二尖瓣反流(MR)在 ADHF 治疗后可能会改善,因为 MR 本质上是动态的。本研究探讨了 ADHF 患者入院时动态严重 MR 的临床意义。
对 784 例因 ADHF 住院的患者进行了经胸超声心动图检查,其中 563 例患者在 ADHF 治疗后至少有轻度 MR,将其分为 3 组:入院时和 ADHF 治疗后均为重度(持续性 MR,n=106);入院时为重度,ADHF 治疗后改善为轻度/中度(动态性 MR,n=149);入院时和 ADHF 治疗后均为轻度/中度(非显著性 MR,n=308)。主要终点定义为 1 年内发生心脏死亡、心力衰竭再住院和二尖瓣介入治疗的复合终点。
动态性 MR 组(44.8%)的主要终点发生率明显高于非显著性 MR 组(22.1%,调整后的危险比[HR]:0.50,95%置信区间[CI]:0.34-0.73,P<0.001),与持续性 MR 组(44.4%,调整后的 HR:1.08,95% CI:0.69-1.67,P=0.75)相似。在左心室射血分数降低(<45%)和保留的亚组患者中,动态性 MR 的风险是一致的(P=0.56)。
在因 ADHF 住院的患者中,入院时出现动态性严重 MR 与非显著性 MR 相比,预后较差,与持续性严重 MR 具有相似的风险。急性动态性 MR 可能是 ADHF 患者的一个潜在治疗靶点。